Immuneed

Linking pre-clinical data to reality

  • CEO: Camilla Oldgren
  • First investment year: 2016
  • Fund: Eastern Mid Sweden
  • Business sector: Life Science

.

Immuneed is a life science biotech company offering a lab-based human whole-blood assay as a specialized service, for detection of immune-related side effects of biopharmaceuticals. The assay can minimize risks related to drug infusion reactions as well as decrease cost for pre-clinical drug development; linking preclinical data to clinical reality.